![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 19, 14190-14197, May 12, 2000
,
,
From the Department of Surgery, Endocrine Unit, Uppsala University
Hospital, S-751 85 Uppsala, Sweden, the
Eukaryotic
Gene Regulation Laboratory, Marie Curie Research Institute, The Chart,
Oxted, Surrey RH8 0TL, United Kingdom, and the
§ Laboratory of Biochemistry and Molecular Biology, The
Rockefeller University, New York, New York 10021
| |
ABSTRACT |
|---|
|
|
|---|
Megalin/low density lipoprotein receptor-related
protein 2 (LRP-2) is an endocytic receptor expressed in highly
specialized cell types such as parathyroid cells and epithelia of the
kidney. Previous experiments identified a nonconsensus TATA element,
with the sequence TAGAAAA, as crucial for accurate and efficient
transcription from the LRP-2 promoter. Here we show that, in addition
to the TAGA element, promoter sequences downstream of the transcription start site contribute significantly to transcription both in
vitro and in transfected cells. Deletion and point mutational
analyses reveal that the promoter region located between positions +5
and +11 (sequence TTTTGGC) is of particular importance. Complementation experiments in nuclear extracts lacking transcription factor IID (TFIID) activity show that TATA-binding protein-associated factors of
TFIID are essential for the function of LRP-2 downstream promoter sequences. Interestingly, DNase I footprinting studies show that the
downstream region between positions +5 and +11 does not significantly affect overall TFIID affinity to the promoter but that it profoundly affects the topology of the TFIID·promoter complex not only
downstream of the transcription start site, but in particular in the
TATA box region. Our observations suggest a model for a novel
downstream sequence function, in which TATA-binding protein-associated
factor-promoter interactions downstream of the transcription start site
modulate TFIID-DNA interactions in the TATA box region.
The process of transcription underlies strong regulatory
mechanisms, restricting expression of most genes to certain cell types
or developmental stages. The establishment of cell-free systems, some
20 years ago, has permitted biochemical fractionation and purification
of a set of six general transcription factors, denoted
TFIIA,1 -B, -D, -E, -F, and
-H, that, in addition to RNA polymerase II, are minimally required for
low (basal) levels of accurate transcription initiation in
vitro. The activity of the general transcription machinery
in vivo is regulated by gene- and cell type-specific transcription activators and repressors as well as various cofactors that are thought to function as mediators between regulatory proteins and individual components of the general transcription machinery (reviewed in Refs. 1 and 2).
A key step in the formation of functional transcription initiation
complexes is the recognition of promoter sequences by components of the
general transcription machinery. Indeed, it has become evident that the
core promoter sequence context has a significant influence on both the
overall efficiency of gene transcription and the ability of individual
genes to respond to various transcription activators (1, 3). Functional
core promoter sequence elements identified to date include the TATA
box, the initiator (Inr), the downstream promoter element (DPE), and
the TFIIB recognition element. The best characterized core promoter
elements are the TATA box, an A/T-rich sequence located about 25-30
nucleotides upstream of the transcription start site that is recognized
by the TATA-binding subunit of TFIID (reviewed in Ref. 4), and the Inr
element, a pyrimidine-rich sequence with the consensus YYA+1N(T/A)YY at the start site of transcription (5, 6).
Both TATA and Inr elements are sufficient to independently direct
accurate transcription initiation in vitro but can also
function in concert in a synergistic manner (see Ref. 7 and references
therein). The DPE was recently identified as a sequence element in many TATA-less, Inr-containing promoters, located some 25-30 nucleotides downstream of the transcription start site with the consensus (A/G)G(A/T)CGTG (8, 9). Finally, the TFIIB recognition element was
identified, by binding site selection, as a GC-rich sequence located
immediately upstream of the TATA box, which can enhance both binding of
TFIIB to the TBP·DNA complex and promoter activity (10).
While the functions of the TATA box and the TFIIB recognition element
sequences correlate well with their relative affinities to their
cognate binding proteins TBP and TFIIB (10, 11), studies in cell-free
metazoan systems (7, 12, 13) and studies in yeast cells (14, 15) have
established a general requirement for TAFIIs in the
function of promoter regions downstream of the TATA element as well as
for the transcription of TATA-less genes (7) where the TATA box-binding
activity of TBP is largely dispensable (16). More specifically,
functional studies with partially reconstituted recombinant
Drosophila TFIID complexes have shown a minimal requirement of TBP, TAFII250, and TAFII150 for
promoter-specific downstream sequence function (13). DNase I
footprinting studies had demonstrated earlier that the human TFIID
multiprotein complex, but not TBP alone, can make contact with promoter
sequences downstream of the TATA element and the transcription start
site of certain core promoter sequences (17-19). More recently, UV
cross-linking experiments have examined the relative disposition of DNA
and TFIID subunits within a human TFIID·promoter complex and have
identified several human and Drosophila TFIID subunits in
close proximity of promoter DNA. These studies suggest that
Drosophila and human TAFII250 and
TAFII150 might directly interact with the Inr element and promoter regions downstream of certain promoters (13, 20, 21) and that
the histone-like Drosophila TFIID subunits
TAFII60 and TAFII40 may contact the DPE (9).
Based on these observations, it has been proposed that downstream
promoter elements function in part by increasing TFIID·promoter
complex formation and/or stability through direct interactions with
TAFIIs. Furthermore, dependent on the presence of TFIIA,
TAFII interactions with downstream promoter regions
may be concomitant with the formation of a stereospecific TFIID·promoter complex (21), consistent with a general requirement for TFIIA in core promoter- and TAFII-dependent
transcription (22-24). Finally, a recent study has identified novel
TAFII- and initiator-dependent cofactors (TICs)
that are, in addition to TFIIA and TAFIIs, required for
core promoter-specific functions of TFIID through the initiator region
of TATA-containing and TATA-less promoters (24). Taken together, these
observations suggest that quantitative or qualitative core promoter
sequence-dependent effects on TFIID promoter binding may
constitute one important step for the functional readout of downstream
core promoter sequence elements.
We previously identified a weak, atypical TATA box (TAGAAAA) as
necessary for transcription of the human megalin/low density lipoprotein receptor-related protein 2 (LRP-2) gene promoter (25). Here, we demonstrate that efficient LRP-2 transcription additionally requires promoter sequences downstream of the transcription start site.
Deletion and point mutation analyses indicate that stimulatory LRP-2
downstream promoter functions are conferred to a large extent by core
promoter sequences located between positions +5 and +11, with no
apparent sequence similarities to the Inr and DPE consensus sequences.
DNase I footprinting experiments reveal that the presence of this
sequence does not significantly affect the overall affinity of TFIID
binding. Instead, TFIID interactions with the +5 to +11 region induce
dramatic qualitative changes in TFIID interactions in the LRP-2 TATA
box region, suggesting the formation of a conformationally distinct
TFIID·promoter complex.
Plasmid Constructions--
A previously described fragment of
the human LRP-2 promoter, containing sequences between positions Proteins and Nuclear Extracts--
HeLa nuclear extracts were
prepared by the method of Dignam et al. (26). HeLa nuclear
extract lacking TBP and TAFIIs NE[ Transfections and Reporter Gene Assays--
JEG-3 cells were
maintained and transfected as described previously (25). For
luminometric determination of promoter activity, cells were transfected
in 60-mm plates with 5 µg of luciferase reporter and 1 µg of
CMV-LacZ in 10 µg of total DNA. Cells were harvested 36 h
post-transfection, and luciferase and In Vitro Transcription and DNase I Footprinting--
In
vitro transcription experiments in untreated HeLa nuclear extracts
were performed as described previously (7). Products were quantified by
primer extension using the GL-2 sequencing primer (Promega). DNase I
footprinting was done essentially as described (21). Templates
containing the respective LRP-2 promoter inserts and flanking vector
sequences, were radiolabeled on the noncoding strand, using
polynucleotide kinase. Similar molar amounts (2.4 fmol/15 µl) of
different templates were used in the binding reactions. Products were
analyzed on 6% (primer extension) or 8% (footprinting) sequencing
gels and quantified by PhosphorImager analysis, and results were
documented by autoradiography.
Downstream Core Promoter Sequences Contribute to Human LRP-2 Gene
Activity--
We have shown previously that LRP-2 promoter activity is
dependent on a weak nonconsensus TATA element with the sequence TAGAAAA located 30 bp upstream of the transcription initiation site (25). Earlier studies demonstrated that introduction of a G·C base pair at
position 3 of the TATAAAA consensus sequence reduces TFIID promoter
activity 50-fold (11). We therefore reasoned that additional core
promoter sequences downstream of the TATA element may contribute to the
LRP-2 promoter activity. Since the LRP-2 promoter appears to lack an
initiator element (consensus YYA+1N(T/A)YY; Ref. 6), we
examined the functional contribution of LRP-2 promoter sequences
downstream of the transcription start site. Two 3'-deletion LRP-2
promoter mutants, encompassing nucleotides
As shown in Fig. 1B, RNA polymerase II-dependent
LRP-2 transcription (compare lanes 1 and
2) was moderately reduced by deletion of the promoter region
between +11 and +52 (compare lanes 1 and 3). Further deletion of sequences to +4, however, resulted
in a dramatic reduction of LRP-2 promoter activity, almost to
background level (Fig. 1B, compare lanes
3 and 4). Importantly, introduction of clustered
point mutations between +5 and +11 in constructs carrying LRP-2
promoter sequences either from
To study the function of LRP-2 downstream promoter regions in living
cells, we co-transfected JEG-3 cells, which express LRP-2, with
reporter plasmids containing the LRP-2 promoter variants fused to a
luciferase reporter gene (Fig. 1A) and a
Taken together, these findings demonstrate a requirement of core
promoter sequences downstream of the transcription start site for
efficient LRP-2 transcription in vitro and in transfected cells. Our data also suggest that a major proportion of LRP-2 downstream promoter function is conferred by the DNA sequence 5'-TTTTGGC-3' located between positions +5 and +11. This sequence appears not to be related to a functional initiator element (consensus YYA+1N(T/A)YY; Ref. 6) or to the recently described DPE in
Drosophila (consensus (A/G)G(A/T)CGT; Refs. 8 and 9) and may
therefore contain a novel downstream core promoter element.
The LRP-2 Downstream Sequence Function Is
TAFII-dependent--
Work from a number of
laboratories has clearly established that TAFIIs perform
critical functions in the binding and the functional readout of core
promoter elements distinct from the TATA element (reviewed in Refs. 1,
3, and 4). To test for a role of TAFIIs in LRP-2 downstream
promoter sequence function, we examined the function of LRP-2
downstream promoter sequences between +5 and +52 on transcription in a
HeLa nuclear extract immunodepleted of TFIID activity (NE[
Taken together, these results demonstrate that LRP-2 downstream
sequence function is TAFII-dependent. They also
indicate that TAFIIs may actually inhibit TBP function in
the absence of LRP-2 downstream promoter sequences, consistent with
earlier observations with other core promoters (13, 27, 31). Similar
results were obtained in analogous experiments using heat-treated HeLa nuclear extracts that lack TFIID activity (Ref. 17; data not shown).
LRP-2 Downstream Sequences Facilitate Promoter Binding by
Components of TFIID in the Presence of the Weak Nonconsensus TATA
Element--
To further investigate the role(s) of TAFIIs
in LRP-2 downstream promoter sequence function, we carried out DNase I
footprinting experiments using radiolabeled DNA fragments containing
various LRP-2 promoter variants, immunoaffinity-purified f:TFIID, and partially purified human TFIIA (21). Binding of f:TFIID to a DNA
fragment containing LRP-2 promoter sequences from
Removal of LRP-2 downstream sequences from +11 to +52 resulted in a
modest reproducible reduction of overall f:TFIID binding to the LRP-2
promoter but did not affect DNase I hypersensitivity upstream from the
TATA element and downstream from the transcription start site (Fig. 3,
compare lanes 1-4 with lanes
5-8), in agreement with the modest, yet reproducible
impairment of transcription observed in vitro and in
vivo (Fig. 1, B, C, and D).
Importantly, and in contrast to our observations with the
Finally, we assessed the contribution of the nonconsensus LRP-2 TATA
element in f:TFIID promoter binding by performing DNase I footprinting
assays with a promoter construct containing LRP-2 sequences from
Taken together, these observations demonstrate that DNA sequences
downstream of the transcription start site contribute to efficient
f:TFIID binding. Interestingly, the presence of the downstream region
between +5 and +11 did not significantly increase the overall affinity
of f:TFIID binding to the LRP-2 promoter (Fig. 3, lanes
5-12) but rather induced strong DNase I hypersensitivity upstream of the TATA element and downstream of the LRP-2 transcription start site. This indicated to us that this particular part of the LRP-2
downstream region may affect the overall topology of the
f:TFIID·LRP-2 promoter complex (see below).
We attempted unsuccessfully to identify the component(s) of TFIID that
contact the LRP-2 downstream promoter region by a photocross-linking method (data not shown) using promoter constructs modified with the
thymidine derivative
5-[N-(p-azidobenzoyl)-3-aminoallyl]-deoxyuridine triphosphate (32). The lack of specifically cross-linked products may
be explained by the fact that the method only probes the vicinity of
the DNA major groove and hence would fail to detect other interactions. Alternatively, the bulky side chain of the
5-[N-(p-azidobenzoyl)-3-aminoallyl]-deoxyuridine monophosphate residues may have interfered with the respective TFIID-promoter interactions.
Promoter Regions Downstream from the Transcription Start Site
Mediate Conformational Changes within the TFIID·Promoter Complex
at Promoter Regions Upstream from the TATA Element and at the
Transcription Start Site--
In order to distinguish qualitative and
quantitative effects of LRP-2 downstream promoter sequences on TFIID
binding, we used LRP-2 promoter constructs engineered to contain a
consensus TATA element, designated
Next, we performed DNase I footprinting experiments to examine the
effects of LRP-2 downstream sequences on f:TFIID promoter binding in
the presence of a consensus TATA box. As expected, conversion of the
TAGA element into a consensus TATA box increased f:TFIID binding to the
LRP-2 promoter, leading to increased protection of the TATA box region
and downstream promoter sequences (Fig. 4B, compare
lanes 1-4 with lanes 5-8). However,
in contrast to the results obtained with promoter templates containing
the wild type LRP-2 TATA sequence TAGAAAA, deletion of LRP-2 downstream sequences between +5 and +52 had no significant quantitative effect on
f:TFIID promoter binding to DNA templates containing a consensus TATA
element (Fig. 4B, compare lanes 5-8
with lanes 9-12; Fig. 3). Most importantly,
while the overall levels of protection in the TATA box region remained
essentially unchanged, the absence of LRP-2 promoter sequences
downstream of +4 resulted in a complete loss of the DNase I
hypersensitivity observed with the full-length promoter constructs in
the regions upstream from the TATA box and downstream from the
transcription start site. This observation implies that TFIID
interactions with LRP-2 downstream promoter regions between positions
+5 and +52 not only contribute to the overall TFIID affinity
(detectable only in the context of a weak TATA sequence; see Fig. 3)
but in addition result in a significant reorganization of the
TFIID·DNA nucleoprotein complex topology. Of particular interest is
that interactions of TFIID with LRP-2 promoter regions downstream of
the transcription start site, largely mediated by DNA sequences located
between +5 and +11 (Fig. 3), strongly affect TFIID-DNA interactions at
the TATA region, 30 base pairs upstream of the transcription start
site. These qualitative effects of LRP-2 downstream sequences on TFIID
binding correlate well with increased transcription in HeLa nuclear
extract (Figs. 1B, 2B, and 4A).
Therefore, our data suggest that LRP-2 promoter sequences downstream of
the transcription start site, in particular the downstream region
located between +5 and +11, contribute to LRP-2 transcription by
facilitating the formation of a specific TFIID·promoter complex
topology that is required for efficient preinitiation complex formation.
TAFII-dependent Transcription through
Downstream Sequences in the LRP-2 Gene--
Our previous experiments
showed that a TAGAAAA sequence in the
The LRP-2 transcription start site sequence is rich in purines (Fig.
1A) and shows no similarity to the Inr element (consensus YYA+1N(T/A)YY; Ref. 6). Furthermore, mutation of a LRP-2
promoter sequence centered around +29 with homology to the DPE
consensus sequence (8) had no detectable effect on TFIID binding and transcription (data not shown). Instead, our deletion and point mutation analyses suggest that a promoter region with the sequence 5'-TTTTGGC-3' located between positions +5 and +11 is of particular importance for efficient LRP-2 transcription. We were unable to detect
significant homologies with this sequence in any other TATA-containing
and initiatorless promoter in the Eukaryotic Promoter Database (33),
including class II promoters for which downstream interactions with
human TFIID have been demonstrated (17, 18). Based on these results, we
speculate that the LRP-2 downstream region between +5 and +11 may
constitute a novel class II core promoter sequence element.
Using HeLa cell nuclear extracts immunodepleted of TBP and
TFIID-specific TAFIIs as a cell-free transcription system,
we compared the effect of the LRP-2 downstream sequences in TBP- and
TFIID-directed transcription. In agreement with earlier studies on core
promoter-specific transcription (7, 12, 13), we find that LRP-2
downstream sequence function is dependent on TAFIIs within
the TFIID complex. We also noted that, in the absence of the LRP-2
downstream sequences, TBP mediated higher absolute levels of
transcription than TFIID, whereas in the presence of the LRP-2
downstream sequences transcription levels with TFIID were higher than
with TBP. This may indicate that TAFIIs actually repress
TBP (TFIID) function in the absence of LRP-2 downstream promoter
functions, similar to observations with other core promoter sequences
(13, 18, 27, 31). Thus, the stimulatory effect of the LRP-2 downstream
region may reflect the relief of TAFII-mediated repression
as well as a net stimulation of TBP (TFIID) function (Ref. 34; see below).
Effects of LRP-2 Downstream Promoter Regions on TFIID
Binding--
Previous studies have demonstrated that downstream
promoter sequences can exert quantitative (overall binding affinity) as well as qualitative (overall topology) effects on TFIID-promoter interactions (reviewed in Refs. 1 and 4). We find that the LRP-2
downstream region stimulates TFIID binding to the LRP-2 promoter
in the presence of TFIIA only very weakly. Instead, DNase I-hypersensitive sites indicated dramatic differences in the overall conformation of the TFIIA·TFIID·LRP-2 promoter complex in the absence and presence of the LRP-2 downstream region. Importantly, changes in TFIID·promoter complex topology occurred not only within the +5 to +11 region itself but were particularly evident upstream of
the LRP-2 TATA box. These effects are
TAFII-dependent, since no DNase I
hypersensitivity upstream of the TATA box region was observed when
bacterially expressed human TBP was used (data not shown). The lack of
DNase I hypersensitivity upstream from the LRP-2 TATA region may
indicate that TBP-TATA interactions in the absence of LRP-2 downstream
sequences are compromised by the presence of TAFIIs within
the TFIID complex. Thus, our results provide, for the first time,
evidence that TAFII interactions with promoter sequences
downstream the transcription start site can in turn exert qualitative
effects on TFIID-promoter interactions around and upstream of the TATA element.
A Potential Model for LRP-2 Downstream Sequence
Function--
Earlier work has established a correlation between
activator-induced (and TFIIA-dependent) isomerization of a
human TFIIA·TFIID·promoter complex characterized by the induction
of TFIID downstream interactions, facilitated recruitment of the
remaining general transcription factors, and stimulation of
transcription (35-37). Thus, core promoter-dependent formation of a stereospecific TFIID·promoter complex may similarly facilitate functional preinitiation complex formation, possibly in
conjunction with additional soluble core promoter sequence-specific cofactors, such as the recently identified TICs (24). However, depending on the core promoter sequence context, TAFIIs
have also been reported to repress TBP function (13, 18, 27, 31). In
particular, the N terminus of Drosophila
TAFII230, the human TAFII250 homologue,
inhibits promoter binding of TBP (38) through interactions of an
N-terminal subdomain I with the TBP DNA-binding surface via structural
mimicry of TBP-TATA box interactions (39). Remarkably, a second
conserved N-terminal subdomain II, that contributes to
TAFII230-mediated repression of TBP function, interacts
with residues on the convex surface of TBP that are crucial for
interaction with TFIIA (40). Indeed, TFIIA seems to be generally
required for TAFII- and core promoter-specific
transcription (22-24) and derepression of
TAFII250-mediated inhibition of human TFIID (41). In
addition, the C-terminal portion of Drosophila
TAFII230/human TAFII250 appears to be involved
in the control of the inhibitory N-terminal domain (38). Keeping in
mind that Drosophila TAFII230 and its human
homologue TAFII250 have also been implicated in direct
TFIID-promoter interactions at and downstream of the transcription start site (13, 21), it is conceivable that interactions of the
C-terminal portion of Drosophila TAFII230/human
TAFII250 with promoter DNA contribute to relief TFIID
autoinhibition by the N-terminal domains in conjunction with TFIIA.
Based on our data and the considerations mentioned above, we favor a
model in which LRP-2 core promoter sequences located between positions
+5 and +11 stimulate LRP-2 transcription by facilitating relief from TFIID autoinhibition through TAFIIs (Fig.
5).
Potential Role(s) of Downstream Promoter Regions in LRP-2 Gene
Regulation--
We found that an LRP-2 promoter template containing a
consensus TATA element but lacking sequences downstream of +4, directed similar levels of transcription as the natural full-length promoter containing the weak TAGA element. This indicates that one role of the
downstream promoter region of the LRP-2 gene may be to complement the
weak TAGA element, to reach a certain level of basal promoter strength.
Also, we note obvious parallels between the LRP-2 gene and the human
gene for glial fibrillary acidic protein, whose expression also is
highly tissue-specific (see Ref. 42 and references therein). Both the
LRP-2 and glial fibrillary acidic protein promoters display stimulation
of TFIID binding and transcription by downstream promoter regions in
the context of very weak TATA sequences (see Refs. 18 and 25; this
paper). Thus, such a promoter architecture may be preferable for cell type-specific gene expression.
Given that activators may stimulate transcription by affecting the
ability of TAFIIs to interact with promoter regions at and
downstream of the transcription start site, a dynamic functional interplay of activator-independent TAFII-promoter
interactions and TAFII-mediated autoinhibition of TFIID may
provide for additional levels of transcription regulation. It may also
contribute to core promoter-specific activity of various activators
(43-48), encouraging speculation that the unique structure of the
LRP-2 core promoter may be a prerequisite for productive interplay with an as yet unidentified enhancer of this gene.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
120
and +52, cloned into the pGL-3 basic vector (25), was used as
polymerase chain reaction template for construction of the deletion and
point mutants outlined in Fig. 1A. Deletion of the LRP-2
promoter in the
120/+11 and
120/+4 constructs replaced the
wild type LRP-2 sequence
+3GCTTTTGGCCACTAGGAGCTGGCGGAGG+30 with
+3GCTTTTGGCGCTAGCCCGGGCTCGAGAT+30
and
+3GCGCTAGCCCGGGCTCGAGATCTGCGAT+30,
respectively (vector sequences in boldface type; +3 and +30 refers to
nucleotide positions relative to the transcription start site). To
generate the
120/+52(mut4-10) construct, the wild type sequence
+3GCTTTTGGC+11 was changed to
GTCTCGGTC, while for
construction of the
120/+11(mut5-8), the same wild type sequence was
changed to GCGCTAGGC. For analysis of promoter
activity in vivo by RNase protection assay, a fragment
containing the SV40 enhancer was inserted downstream of the luciferase
gene in some of the reporters, as outlined in the text (see Fig.
1D). All constructs were verified by DNA sequencing.
D] was prepared as
described (27). Highly purified (Fig. 2A) recombinant, bacterially expressed human six-histidine-tagged TBP (6His:TBP), highly
purified (Fig. 2A) FLAG epitope-tagged human TFIID
(f:TFIID), and partially purified human TFIIA were prepared as
described previously (19, 21, 27). The TBP content of f:TFIID was determined by quantitative immunoblot analysis.
-galactosidase activities were
determined luminometrically. For analysis of RNA, cells were
transfected in 90-mm plates, with 10 µg of luciferase reporter
plasmid/SV40, 100 ng of OVEC-REF (28) and calf thymus DNA to 18 µg
total per plate. RNA was isolated 36 h after transfection, by the
Nonidet P-40 lysis method (29). RNase protection analysis was performed
as described (30), utilizing probes specific for the RNAs derived from
the different mutant promoters. Products were quantified by
PhosphorImager analysis. Numbers were normalized for differences in
product content of the radiolabeled ribonucleotide ([32P]UTP) and for differences in transfection
efficiency, as determined by the signal obtained from the
co-transfected OVEC-REF.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
120 to +11 and
120 to +4
(Fig. 1A), were constructed,
and their transcription activities were compared with that of the
full-length promoter (
120/+52; Ref. 25) in vitro and in
transfected cells.

View larger version (30K):
[in a new window]
Fig. 1.
Downstream core promoter sequences contribute
to human LRP-2 gene activity. A, nucleotide sequence of
the human LRP-2 promoter between positions
40 and +15
(top) and schematic description of the constructs used in
this study. The TAGAAAA element is boxed, and the region
between +5 and +11 studied extensively in this paper is
underlined. The position of the start site of transcription
(25) is indicated (arrow). B, in vitro
transcription assays were performed with the indicated constructs,
using 90 µg of HeLa cell nuclear extract protein per reaction.
Products were analyzed by primer extension. Relative transcription
levels determined by PhosphorImager analysis (Molecular Dynamics, Inc.,
Sunnyvale, CA) are shown. C, transient expression of LRP-2
promoter variants in JEG-3 cells co-transfected with a CMV-LacZ
reference plasmid. Cells were transfected in triplicate, and the mean
relative luciferase activities normalized for differences in
-galactosidase activity are shown. The relative activity for each
construct differed by less than 20% between experiments. D,
quantitative RNase protection analysis of RNA prepared from JEG-3 cells
co-transfected in duplicate with the indicated LRP-2 reporter
constructs and the reference plasmid, OVEC-REF. Lane
4 represents a reaction run with RNA from nontransfected
cells. The relative transcription levels, normalized for differences in
product content of radiolabeled ribonucleotide ([32P]UTP)
and reference gene signal, are shown below the
autoradiogram.
120 to +52 (yielding
120/+52
mut(4-10)) or from
120/+11 (yielding
120/+11 mut(5-8); Fig.
1A) also strongly reduced LRP-2 promoter activity (Fig.
1B, compare lane 1 with
lane 5, and compare lane 3 with lane 6). These observations demonstrate that
core promoter sequences downstream of the transcription start site
significantly contribute to efficient LRP-2 transcription in HeLa
nuclear extracts and that a major proportion of LRP-2 downstream
promoter function is conferred by the DNA sequence 5'-TTTTGGC-3'
located between +5 and +11.
-galactosidase reference plasmid. As shown in Fig. 1C, deletion of LRP-2
promoter sequences from +11 to +52 reduced luciferase activities in the respective cell extracts by 50%, while further deletion of sequences from +11 to +4 resulted in an additional 2-3-fold reduction of LRP-2
promoter activity. Importantly, and in agreement with our in
vitro data, clustered point mutation of promoter sequences between
+5 and +11 affected LRP-2 transcription to the same extent as the
deletion of promoter sequences between +5 and +11 (Fig. 1C).
We confirmed that changes in luciferase activity in these assays indeed
reflected changes in intracellular luciferase mRNA levels by
performing RNase protection assays (Fig. 1D) on total RNA
from cells co-transfected with derivatives of our luciferase reporter
gene constructs carrying the SV40 enhancer upstream of the LRP-2
promoter and the OVEC-REF plasmid as a reference (28).
D]; Ref.
27). As shown in Fig. 2B,
transcription from the LRP-2 promoter in this extract was completely
dependent on the addition of either highly purified recombinant human
6His:TBP or equivalent amounts (TBP content) of immunoaffinity-purified f:TFIID (Fig. 2A; Refs. 19 and 27). In the presence of
f:TFIID, the relative levels of transcription from the parental
120/+52 constructs and the two deletion mutants in NE[
D] were
comparable with those observed in untreated extract (compare
lanes 3, 6, and 9 of Fig.
2B with lanes 1, 3, and
4 of Fig. 1B). Thus, the addition of highly
purified f:TFIID (Fig. 2A) was sufficient to restore LRP-2
downstream sequence functions in NE[
D]. Importantly, transcription
levels from the LRP-2 promoter containing downstream promoter sequences
up to +52 was significantly higher (>5-fold) with f:TFIID than with
similar amounts of human 6His:TBP (Fig. 2B, compare
lane 2 with lane 3). This
was also true for the
120/+11 construct (lanes
5 and 6), although the difference in absolute transcription levels was somewhat lower (3.4-fold). Despite the very
weak absolute transcription levels, transcription from the
120/+4
template was reproducibly higher with 6His:TBP than with f:TFIID
(lanes 8 and 9).

View larger version (28K):
[in a new window]
Fig. 2.
LRP-2 downstream sequence function is
TAFII-dependent. A,
Coomassie-stained SDS gel of 6His:TBP (left) and
silver-stained gradient SDS gel of f:TFIID (right) used in
this study. B, 200 ng of the indicated promoter constructs
were transcribed using 120 µg of HeLa nuclear extract immunodepleted
of TFIID (NE[
D]) and 60 ng of 6His:TBP or equivalent amounts of
f:TFIID (60 ng of TBP content) as indicated. Specific transcripts were
analyzed and quantified as described in the legend to Fig.
1B.
120 to +52 was
relatively weak, presumably due to the low affinity TATA box sequence
present in the LRP-2 promoter (Ref. 11; see below). However, detectable
DNase I protection extended over a broad promoter region from about
position
40 to +30 (Fig. 3,
lanes 1-4). Importantly, f:TFIID binding induced
strong DNase I hypersensitivity centered around positions
50 and
60
upstream of the TAGA element, as well as within the LRP-2 downstream
promoter region at positions +7 and +8.

View larger version (53K):
[in a new window]
Fig. 3.
LRP-2 downstream sequences facilitate
promoter binding by components of TFIID in the presence of the weak
nonconsensus TATA element. DNase I footprint analysis with a
full-length and truncated LRP-2 promoter templates radiolabeled on the
noncoding strand, in the presence (+) or absence (
) of
immunoaffinity-purified human f:TFIID and partially purified human
TFIIA. M, G/A sequencing reaction. The arrows
indicate DNase I-hypersensitive sites.
120/+52 and
120/+11 constructs, further deletion of LRP-2 promoter sequences to
+4 did not significantly reduce overall f:TFIID binding but instead completely abolished the induction of DNase I hypersensitivity upstream
from the TATA element and downstream from the transcription start site
(Fig. 3, compare lanes 9-12 with
lanes 5-8). These results suggest that LRP-2
promoter sequences from +5 to +11 are major determinants of
f:TFIID·DNA complex formation, consistent with their importance for
efficient LRP-2 transcription in vitro and in transfected
cells (Fig. 1, B, C, and D).
10
to +52, lacking the TAGA element. Surprisingly, we were able to detect
weak f:TFIID binding, protecting a region from DNase I digestion
downstream of the transcription start site and to around position
40
(Fig. 3, lanes 13-15). Thus, although the TAGA element at
position
30 is required for detectable LRP-2 transcription in
vitro (25), LRP-2 downstream promoter sequences between positions
10 and +52 appear to be sufficient for low affinity f:TFIID binding.
120/+52(G3T) and
120/+4(G3T),
respectively ("G3T" for TATAAAA; Fig. 1A).
Consistent with previous observations (25), conversion of the TAGAAAA
sequence to a consensus TATA box increased LRP-2 promoter activity more
than 10-fold (Fig. 4A, compare
lanes 1 and 3). Interestingly,
deletion of promoter sequences downstream from the transcription start
site reduced LRP-2 transcription from promoter constructs carrying a
consensus TATA element and promoter constructs with the wild type TAGA
element to an approximately similar extent. This result suggests that LRP-2 downstream promoter functions are independent of a particular TATA element sequence. Furthermore, absolute transcription levels from
LRP-2 promoter constructs that contained a consensus TATA box but
lacked LRP-2 downstream sequences were comparable with absolute
transcription levels from constructs containing wild type LRP-2
promoter sequences from
120 to +52 (Fig. 4A, compare lanes 1 and 4). Thus, a consensus TATA
sequence can substitute for promoter sequences downstream of +4 to
mediate wild type levels of LRP-2 transcription.

View larger version (33K):
[in a new window]
Fig. 4.
Promoter regions downstream of the
transcription start site facilitate LRP-2 transcription by mediating
conformational changes within the TFIID·promoter complex at promoter
regions upstream from the TATA element and downstream from the
transcription start site. A, in vitro
transcription assays were performed with the indicated templates as
described in the legend to Fig. 1B. B, DNase I
footprint experiments were performed with the indicated templates as
described in the legend to Fig. 3.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
30 region was required for
human LRP-2 promoter activity (25). However, earlier reports suggested
that a TAGA element would not be sufficient in mediating efficient
TFIID binding and transcription (11). We therefore looked for
additional core promoter sequences that would contribute to high levels
of LRP-2 transcription.

View larger version (17K):
[in a new window]
Fig. 5.
A potential model for LRP-2 downstream
sequence function. A, binding of human TFIID to the
LRP-2 promoter requires (partial) relief from
TAFII-mediated TFIID autoinhibition, e.g.
displacement of the N-terminal domain I (N'I) of
TAFII250 from the DNA-binding surface of TBP (34, 39).
B, in the absence of the LRP-2 downstream promoter regions,
additional inhibitory interactions within the TFIID complex,
e.g. between TBP and TAFII250/230 N-terminal
domain II (N'II; Ref. 40), remain unaffected.
C, interactions between TAFIIs within TFIID and
LRP-2 downstream promoter sequences reverse remaining autoinhibitory
TFIID functions via conformational changes within the TFIID·DNA
complex, allowing efficient preinitiation complex formation and
subsequent transcription initiation. The identity of TFIID components
that contact the LRP-2 downstream promoter region is not known.
| |
ACKNOWLEDGEMENT |
|---|
We are greatly indebted to Peter Lillhager for excellent technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported by grants from the Swedish Medical Research Council, Uppsala University, and the Marie Curie Research Institute (to G. W., A. K., and T. O., respectively).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 46-18-662965; Fax: 46-18-553601; E-mail: Gunnar.Westin@kirurgi.uu.se.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
TFIIA-H, transcription factors IIA-H, respectively;
Inr, initiator;
DPE, downstream promoter element;
TBP, TATA-binding protein;
TAFII, TBP-associated factor;
LRP-2, low density
lipoprotein receptor-related protein 2;
6His:TBP, hexahistidine-tagged
TBP;
f:TFIID, FLAG epitope-tagged TFIID;
NE[
D], HeLa nuclear
extract lacking TBP and TAFIIs.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Roeder, R. G. (1996) Trends Biochem. Sci. 21, 327-335[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Orphanides, G.,
Lagrange, T.,
and Reinberg, D.
(1996)
Genes Dev.
10,
2657-2683 |
| 3. | Verrijzer, C. P., and Tjian, R. (1996) Trends Biochem Sci. 21, 338-342[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Burley, S. K., and Roeder, R. G. (1996) Annu. Rev. Biochem. 65, 769-799[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Smale, S. T., and Baltimore, D. (1989) Cell. 57, 103-113[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Javahery, R.,
Khachi, A.,
Lo, K.,
Zenzie-Gregory, B.,
and Smale, S. T.
(1994)
Mol. Cell. Biol.
14,
116-127 |
| 7. | Martinez, E., Chiang, C. M., Ge, H., and Roeder, R. G. (1994) EMBO J. 13, 3115-3126[Medline] [Order article via Infotrieve] |
| 8. |
Burke, T. W.,
and Kadonaga, J. T.
(1996)
Genes Dev.
10,
711-724 |
| 9. |
Burke, T. W.,
and Kadonaga, J. T.
(1997)
Genes Dev.
11,
3020-3031 |
| 10. |
Lagrange, T.,
Kapanidis, A. N.,
Tang, H.,
Reinberg, D.,
and Ebright, R. H.
(1998)
Genes Dev.
12,
34-44 |
| 11. |
Wobbe, C. R.,
and Struhl, K.
(1990)
Mol. Cell. Biol.
10,
3859-3867 |
| 12. |
Kaufmann, J.,
and Smale, S. T.
(1994)
Genes Dev.
8,
821-829 |
| 13. | Verrijzer, C. P., Chen, J. L., Yokomori, K., and Tjian, R. (1995) Cell 81, 1115-1125[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Moqtaderi, Z., Bai, Y., Poon, D., Weil, P. A., and Struhl, K. (1996) Nature 383, 188-191[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Shen, W. C., and Green, M. R. (1997) Cell 90, 615-624[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Martinez, E.,
Zhou, Q.,
L'Etoile, N. D.,
Oelgeschläger, T.,
Berk, A. J.,
and Roeder, R. G.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
11864-11868 |
| 17. |
Nakajima, N.,
Horikoshi, M.,
and Roeder, R. G.
(1988)
Mol. Cell. Biol.
8,
4028-4040 |
| 18. | Nakatani, Y., Horikoshi, M., Brenner, M., Yamamoto, T., Besnard, F., Roeder, R. G., and Freese, E. (1990) Nature 348, 86-88[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Chiang, C. M., Ge, H., Wang, Z., Hoffmann, A., and Roeder, R. G. (1993) EMBO J. 12, 2749-2762[Medline] [Order article via Infotrieve] |
| 20. |
Verrijzer, C. P.,
Yokomori, K.,
Chen, J. L.,
and Tjian, R.
(1994)
Science
264,
933-941 |
| 21. | Oelgeschläger, T., Chiang, C. M., and Roeder, R. G. (1996) Nature 382, 735-738[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Hansen, S. K., and Tjian, R. (1995) Cell. 82, 565-575[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Emami, K. H.,
Jain, A.,
and Smale, S. T.
(1997)
Genes Dev.
11,
3007-3019 |
| 24. |
Martinez, E.,
Ge, H.,
Tao, Y.,
Yuan, C. X.,
Palhan, V.,
and Roeder, R. G.
(1998)
Mol. Cell. Biol.
18,
6571-6583 |
| 25. | Knutson, A., Hellman, P., Akerstrom, G., and Westin, G. (1998) DNA Cell Biol. 17, 551-560[Medline] [Order article via Infotrieve] |
| 26. |
Dignam, J. D.,
Lebovitz, R. M.,
and Roeder, R. G.
(1983)
Nucleic Acids Res.
11,
1475-1489 |
| 27. | Oelgeschläger, T., Tao, Y., Kang, Y. K., and Roeder, R. G. (1998) Mol Cell. 1, 925-931[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Westin, G.,
Gerster, T.,
Muller, M. M.,
Schaffner, G.,
and Schaffner, W.
(1987)
Nucleic Acids Res.
15,
6787-6798 |
| 29. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , pp. 7.12-7.15, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 30. | Forsberg, M., and Westin, G. (1991) EMBO J. 10, 2543-2551[Medline] [Order article via Infotrieve] |
| 31. |
Guermah, M.,
Malik, S.,
and Roeder, R. G.
(1998)
Mol. Cell. Biol.
18,
3234-3244 |
| 32. | Bartholomew, B., Kassavetis, G. A., Braun, B. R., and Geiduschek, E. P. (1990) EMBO J. 9, 2197-2205[Medline] [Order article via Infotrieve] |
| 33. |
Perier, R. C.,
Junier, T.,
Bonnard, C.,
and Bucher, P.
(1999)
Nucleic Acids Res.
27,
307-309 |
| 34. | Burley, S. K., and Roeder, R. G. (1998) Cell 94, 551-553[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Horikoshi, M., Hai, T., Lin, Y. S., Green, M. R., and Roeder, R. G. (1988) Cell 54, 1033-1042[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Hai, T. W., Horikoshi, M., Roeder, R. G., and Green, M. R. (1988) Cell 54, 1043-1051[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
Chi, T.,
and Carey, M.
(1996)
Genes Dev.
10,
2540-2550 |
| 38. |
Kokubo, T.,
Yamashita, S.,
Horikoshi, M.,
Roeder, R. G.,
and Nakatani, Y.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
3520-3524 |
| 39. | Liu, D., Ishima, R., Tong, K. I., Bagby, S., Kokubo, T., Muhandiram, D. R., Kay, L. E., Nakatani, Y., and Ikura, M. (1998) Cell 94, 573-583[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Kokubo, T.,
Swanson, M. J.,
Nishikawa, J. I.,
Hinnebusch, A. G.,
and Nakatani, Y.
(1998)
Mol. Cell. Biol.
18,
1003-1012 |
| 41. |
Ozer, J.,
Mitsouras, K.,
Zerby, D.,
Carey, M.,
and Lieberman, P. M.
(1998)
J. Biol. Chem.
273,
14293-14300 |
| 42. |
Besnard, F.,
Brenner, M.,
Nakatani, Y.,
Chao, R.,
Purohit, H. J.,
and Freese, E.
(1991)
J. Biol. Chem.
266,
18877-18883 |
| 43. | Simon, M. C., Fisch, T. M., Benecke, B. J., Nevins, J. R., and Heintz, N. (1988) Cell 52, 723-729[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Wefald, F. C., Devlin, B. H., and Williams, R. S. (1990) Nature 344, 260-262[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Das, G., Hinkley, C. S., and Herr, W. (1995) Nature 374, 657-660[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Emami, K. H., Navarre, W. W., and Smale, S. T. (1995) Mol. Cell. Biol. 15, 5906-5916[Abstract] |
| 47. |
Merli, C.,
Bergstrom, D. E.,
Cygan, J. A.,
and Blackman, R. K.
(1996)
Genes Dev.
10,
1260-1270 |
| 48. |
Ohtsuki, S.,
Levine, M.,
and Cai, H. N.
(1998)
Genes Dev.
12,
547-556 |
This article has been cited by other articles:
![]() |
S. Pauli, H. M. Rothnie, G. Chen, X. He, and T. Hohn The Cauliflower Mosaic Virus 35S Promoter Extends into the Transcribed Region J. Virol., November 15, 2004; 78(22): 12120 - 12128. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-P. Zhou, C. Wong, R. Su, S. C. Crable, K. P. Anderson, and P. G. Gallagher Human potassium chloride cotransporter 1 (SLC12A4) promoter is regulated by AP-2 and contains a functional downstream promoter element Blood, June 1, 2004; 103(11): 4302 - 4309. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Carystinos, M. Kandouz, M. A. Alaoui-Jamali, and G. Batist Unexpected Induction of the Human Connexin 43 Promoter by the Ras Signaling Pathway Is Mediated by a Novel Putative Promoter Sequence Mol. Pharmacol., April 1, 2003; 63(4): 821 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Abrescia, E. De Gregorio, M. Frontini, R. Mantovani, and P. Di Nocera A Novel Intragenic Sequence Enhances Initiator-dependent Transcription in Human Embryonic Kidney 293 Cells J. Biol. Chem., May 24, 2002; 277(22): 19594 - 19599. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. He, J. Futterer, and T. Hohn Contribution of downstream promoter elements to transcriptional regulation of the rice tungro bacilliform virus promoter Nucleic Acids Res., January 15, 2002; 30(2): 497 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Smale Core promoters: active contributors to combinatorial gene regulation Genes & Dev., October 1, 2001; 15(19): 2503 - 2508. [Full Text] [PDF] |
||||
![]() |
|